Vericel Corp. (VCEL)

[realfast95]

Vericel Announces Appointment of Jonathan Hopper as Chief Medical Officer

Today : Monday 20 August 2018
Click Here for more Vericel Corporation Charts.

Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced the appointment of Jonathan Hopper as Chief Medical Officer.

Dr. Hopper formerly served as Senior Medical Director, Orthopedic Clinical Development for Ferring Pharmaceuticals, where he was responsible for establishing and executing the company’s strategy for Orthopedic clinical development. Prior to joining Ferring Pharmaceuticals, he served in a number of senior medical roles including Vice President, Global Medical Director for Stryker Corporation. Dr. Hopper also has significant medical device regulatory experience having served as a Senior Medical Officer for the UK Medicines and Healthcare products Regulatory Agency. Dr. Hopper graduated with a M.B. Ch.B. from Birmingham University Medical School UK, is a Fellow of the Royal College of Surgeons, Edinburgh, and attained an M.B.A. at Keele University UK.

"Jon’s experience and expertise in orthopedics, wound care, and combination biologic device products are an ideal fit with Vericel’s current business and strategic focus,” said Nick Colangelo, president and chief executive officer of Vericel. "Jon will play a key role in the execution of our life cycle management initiatives as well as our efforts to expand our product portfolio by accessing assets complementary to our existing business.”